NCT03365895View on ClinicalTrials.gov

Diffusion Tensor Imaging in Predicting Development of Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer (CIPN)

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 11, 2017

Primary Completion Date

September 30, 2019

Study Completion Date

October 2, 2020

Conditions
Breast CarcinomaBreast CancerNeuropathy;PeripheralNeuropathy
Interventions
PROCEDURE

Diffusion Tensor Imaging

Undergo non-enhanced MRI using MRN and DTI

OTHER

Laboratory Biomarker Analysis

Correlative studies

PROCEDURE

Magnetic Resonance Imaging

Undergo non-enhanced MRI using MRN and DTI

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

85724

The University of Arizona Cancer Center, Tucson

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Arizona

OTHER

NCT03365895 - Diffusion Tensor Imaging in Predicting Development of Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer (CIPN) | Biotech Hunter | Biotech Hunter